Schedule 13D ownership disclosure
N/A
Security class unavailable · CUSIP: 01345P106
Event date: 2019-11-06
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 0.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-20-275578
- Form type
- SC 13D
- Filer
- ALBIREO PHARMA, INC.
- CIK
- CIK 1322505
- Filed
- Oct 23, 2020
- Reporting period
- Nov 06, 2019
- Description
- Schedule 13D beneficial ownership